Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
about
Vitamin D and urological cancersVitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidenceNutrition, dietary interventions and prostate cancer: the latest evidenceInvestigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a ReviewVitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions.Genome-wide association study of circulating vitamin D-binding proteinVitamin D and Chronic DiseasesSerum vitamin D, vitamin D binding protein, and risk of colorectal cancerPlasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.Serum vitamin D, vitamin D binding protein, and lung cancer survivalSerum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialPlasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany studyAssociations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control studyCirculating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancerBoth serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to GoProteomic profile of saliva and plasma from women with impalpable breast lesions.Normalized vitamin D metabolite concentrations are better correlated to pharmacological effects than measured concentrations.Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.Vitamins, metabolomics, and prostate cancer.Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.Measurement of Vitamin D for Epidemiologic and Clinical Research: Shining Light on a Complex Decision.
P2860
Q26739735-28CC402D-E7FC-44C3-B4D9-9D41D32E0796Q26998011-433AB7DD-092E-48C9-8AE1-2F68736D1FB5Q28084566-93CF011E-81A3-49A9-9987-2707A6597B35Q31090216-DC9DAE73-5C4B-4F74-9D00-F8BC90A2093DQ33608600-F3CF13B6-02E7-4A8D-B37B-703997E9A6C1Q33614777-4589C7EE-45E5-4075-97C2-BF7DFCEA3390Q33714268-78C3EBEF-D29A-4504-BDB4-3ABC108F3118Q33921538-25D29CE9-1A4B-492F-B620-743A7B40E9E9Q34314694-108B5D22-C4F9-4040-B647-C4D7AF52E35AQ34713803-6B6D8EDE-5F1B-4D7A-80A2-08B77436F2DCQ34898979-77A7B8B6-EA66-4464-A60B-F8CBBF913D7EQ34919132-7D56F044-C628-412A-9751-23C214E37C87Q34983624-EB502C0D-D703-4772-9F03-EB8C2C9B1187Q34997116-836AA66B-BE4E-4556-B1F5-6AE2B3FCF7D9Q35755412-D5411F35-B18E-4548-93D6-FEE44EC2A9F2Q35925081-0322E26E-6CF1-4D8C-9CA9-57F7C6541BBAQ37205974-22CA8DAB-3F44-49D7-B5F0-8B36ED5E97A2Q37474227-224240A4-5738-49F0-B9DE-49DB43D15EA7Q37649866-AD3BBE1C-F033-44C8-853D-98133765742BQ38401811-6303785A-B01B-43FF-B6FB-C895C011B642Q38795645-883E17B6-EADE-454F-A897-BF4B6A207D2DQ39658509-948A0DDB-FD61-4233-8036-8A283D327DA9Q40622136-D4B4A46A-5625-4610-B55F-B062D69B14F5Q44190698-3C9635F0-2328-4740-B631-7B230DD78C35Q47666967-A4234AD9-6BC3-45F4-9FE8-0D1668B6F777
P2860
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@ast
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@en
type
label
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@ast
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@en
prefLabel
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@ast
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@en
P2093
P2860
P50
P356
P1476
Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer
@en
P2093
Helen Rager
Stephanie J Weinstein
William Kopp
P2860
P304
P356
10.1002/IJC.27969
P577
2012-12-27T00:00:00Z